Alyeska reports 7.17% stake in Cantor Equity

Accepted by SEC EDGAR 02/17/2026 - 04:34 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Alyeska Investment Group and affiliates have disclosed a passive stake in Cantor Equity Partners II, Inc. They report beneficial ownership of 1,763,546 Class A ordinary shares, representing 7.17% of the company’s outstanding common stock, based on 24,580,000 shares reported as outstanding.

The filing is a Schedule 13G, indicating the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Cantor Equity Partners II.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake in Cantor Equity Partners II (CEPT) did Alyeska report?

Alyeska and related reporting persons disclosed beneficial ownership of 1,763,546 Class A ordinary shares of Cantor Equity Partners II, Inc. This represents 7.17% of the company’s outstanding common stock, based on 24,580,000 shares reported as outstanding in a prior Form 10-Q.

Which entities are reporting beneficial ownership in CEPT on this Schedule 13G?

The Schedule 13G lists three reporting persons: Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh. Each reports the same beneficial ownership figures and shared voting and dispositive power over 1,763,546 Class A ordinary shares of Cantor Equity Partners II, Inc.

How much of CEPT’s share class does Alyeska’s 1,763,546 shares represent?

The reported 1,763,546 Class A ordinary shares represent 7.17% of Cantor Equity Partners II, Inc.’s outstanding common stock. This percentage is calculated using 24,580,000 shares outstanding, as disclosed in the issuer’s Form 10-Q filed on November 14, 2025.

Does the Alyeska Schedule 13G for CEPT indicate an attempt to influence control?

No. The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Cantor Equity Partners II, Inc., consistent with a passive investment reported on Schedule 13G rather than a control-seeking position.

What voting and dispositive powers over CEPT shares does Alyeska report?

The reporting persons disclose zero sole voting and dispositive power, and shared voting and shared dispositive power over 1,763,546 Class A ordinary shares. This means decisions to vote or dispose of these shares are made jointly, rather than by any single reporting person alone.

What date triggered Alyeska’s Schedule 13G filing for Cantor Equity Partners II?

The date of the event requiring the Schedule 13G filing is listed as December 31, 2025. This date reflects when the ownership position met the regulatory threshold that triggered the need to report beneficial ownership of Cantor Equity Partners II, Inc. shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Cantor Equity Partners II, Inc.

(Name of Issuer)

Class A ordinary shares, par value

(Title of Class of Securities)

G1827P106

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G1827P106

1

Names of Reporting Persons

Alyeska Investment Group, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,763,546.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,763,546.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,763,546.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.17 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. G1827P106

1

Names of Reporting Persons

Alyeska Fund GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,763,546.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,763,546.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,763,546.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.17 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. G1827P106

1

Names of Reporting Persons

Anand Parekh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,763,546.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,763,546.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,763,546.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.17 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Cantor Equity Partners II, Inc.
(b)	Address of issuer's principal executive offices: 110 East 59th Street, New York, NY, 10022
Item 2.
(a)	Name of person filing: (i) Alyeska Investment Group, L.P. (ii) Alyeska Fund GP, LLC (iii) Anand Parekh
(b)	Address or principal business office or, if none, residence: (i) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601
(c)	Citizenship: (i) Alyeska Investment Group, L.P. - Delaware (ii) Alyeska Fund GP, LLC - Delaware (iii) Anand Parekh - United States of America
(d)	Title of class of securities: Class A ordinary shares, par value
(e)	CUSIP No.: G1827P106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,763,546
(b)	Percent of class: 7.17%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 1,763,546
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 1,763,546
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alyeska Investment Group, L.P.

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	02/17/2026

Alyeska Fund GP, LLC

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	02/17/2026

Anand Parekh

Signature:	Anand Parekh
Name/Title:	Anand Parekh | Self
Date:	02/17/2026

Exhibit Information

The reporting persons are the beneficial owners of 1,763,546 common shares of the Issuer. The percentage of beneficial ownership is based on 24,580,000 shares of the registrant's common stock outstanding as reported on the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 14, 2025. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.